Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
295.75
+3.68 (1.26%)
At close: Mar 17, 2026, 4:00 PM EDT
297.97
+2.22 (0.75%)
After-hours: Mar 17, 2026, 7:50 PM EDT

Elevance Health Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21
Cash & Equivalents
9,4918,7138,5607,5008,2887,8666,4976,2266,52610,9199,99110,1427,3878,8726,4566,1614,8805,4905,2589,326
Short-Term Investments
26,62427,50326,23226,15226,39330,06729,49430,04129,84327,97628,29328,02826,90527,02927,33727,88128,14828,46727,59428,185
Cash & Short-Term Investments
36,11536,21634,79233,65234,68137,93335,99136,26736,36938,89538,28438,17034,29235,90133,79334,04233,02833,95732,85237,511
Cash Growth
4.13%-4.53%-3.33%-7.21%-4.64%-2.47%-5.99%-4.99%6.06%8.34%13.29%12.13%3.83%5.73%2.86%-9.25%7.47%14.08%4.24%45.41%
Accounts Receivable
15,23514,65715,91915,60513,05512,34413,33713,17312,46011,63911,32712,03211,74610,55510,60111,3289,6919,3579,4399,220
Other Receivables
6,3077,6927,2066,5766,0166,0555,8815,1205,4055,2935,1964,6784,2983,6513,6003,3343,7493,4503,2463,071
Total Trade Receivables
21,54222,34923,12522,18119,07118,39919,21818,29317,86516,93216,52316,71016,04414,20614,20114,66213,44012,80712,68512,291
Other Current Assets
5,3445,2135,4075,2885,1906,5147,0656,3885,7955,3584,9364,9435,2815,4965,6615,1934,6545,1404,7014,693
Total Current Assets
63,00163,77863,32461,12158,94262,84662,27460,94860,02961,18559,74359,82355,61755,60353,65553,89751,12251,90450,23854,495
Net Property, Plant & Equipment
4,6794,6574,6414,6174,6524,5054,4504,4514,3594,2484,5474,4184,3164,1974,0903,9863,9193,8353,7333,533
Other Intangible Assets
11,20011,32711,49011,94012,09410,32510,44710,71010,27310,49110,70310,91510,31510,53610,76210,58810,61510,74910,5409,352
Goodwill
28,34428,45128,36828,42028,27725,96725,96225,94725,31725,29125,27425,27324,38324,38124,36724,25124,22824,18424,39921,708
Long-Term Investments
11,96011,75911,55311,22710,78410,2877,6597,5936,9836,9346,7686,7546,4376,1386,0015,9615,8575,5845,4985,032
Other Long-Term Assets
2,3102,7772,5622,3922,1402,6032,1962,2451,9672,3292,1331,8571,6872,1712,0021,8031,7191,8041,6891,563
Total Assets
121,494122,749121,938119,717116,889116,533112,988111,894108,928110,478109,168109,040102,755103,026100,877100,48697,46098,06096,09795,683
Accounts Payable
7,3226,0857,2787,1316,9276,2555,7605,6586,9105,9835,0334,8735,6074,9635,8505,4934,9705,9605,5985,329
Short-Term Debt
1501803602503653602251,575225-265265265265175275275175175-
Current Portion of Long-Term Debt
1,0997491,6481,6431,6492,1002,9002,9001,649799--1,5002,2492,2483,0971,599849849700
Unearned Revenue
1,4931,8311,5611,6401,5081,7931,4811,4741,4024,3324,4584,3941,1123,7029711,2101,1539541,0811,139
Other Current Liabilities
30,97132,03332,98732,03430,13231,52531,44732,72731,60532,22331,81532,35731,21230,10830,06429,65826,88827,22426,09127,581
Total Current Liabilities
41,03540,87843,83442,69840,58142,03341,81344,33441,79143,33741,57141,88939,69641,28739,30839,73334,88535,16233,79434,749
Long-Term Debt
30,79731,17328,17828,11029,21824,68824,56121,97623,24624,04524,85925,20122,34921,25821,16519,88321,15721,76122,21722,534
Other Long-Term Liabilities
5,6366,6166,0756,2895,6645,9334,3174,8744,4864,5574,4264,4904,3804,4384,5374,8395,2905,3295,0404,482
Total Long-Term Liabilities
36,43337,78934,25334,39934,88230,62128,87826,85027,73228,60229,28529,69126,72925,69625,70224,72226,44727,09027,25727,016
Total Liabilities
77,46878,66778,08777,09775,46372,65470,69171,18469,52371,93970,85671,58066,42566,98365,01064,45561,33262,25261,05161,765
Preferred Stock
--------0-----------
Common Stock
22222222222222222222
Additional Paid-in Capital
8,9388,9088,9318,8668,9119,1059,0018,8838,8688,8308,7618,6979,0849,1699,1349,1519,1489,1389,1099,253
Accumulated Other Comprehensive Income
-451-543-760-911-1,147-489-1,387-1,365-1,313-2,512-2,166-2,050-2,490-2,784-2,149-1,236-178-103-17-195
Retained Earnings
35,39335,58635,54934,54633,54935,15734,57533,08831,74932,10331,60830,70729,64729,60428,82528,05827,08826,70025,87424,793
Total Common Shareholders' Equity
43,88243,95343,72242,50341,31543,77542,19140,60839,30638,42338,20537,35636,24335,99135,81235,97536,06035,73734,96833,853
Minority Interest
144129129117111104106102991161071048752555668717865
Shareholders' Equity
44,02644,08243,85142,62041,42643,87942,29740,71039,40538,53938,31237,46036,33036,04335,86736,03136,12835,80835,04633,918
Total Liabilities & Equity
121,494122,749121,938119,717116,889116,533112,988111,894108,928110,478109,168109,040102,755103,026100,877100,48697,46098,06096,09795,683
Total Debt
32,04632,10230,18630,00331,23227,14827,68626,45125,12024,84425,12425,46624,11423,77223,58823,25523,03122,78523,24123,234
Net Cash (Debt)
4,0694,1144,6063,6493,44910,7858,3059,81611,24914,05113,16012,70410,17812,12910,20510,7879,99711,1729,61114,277
Net Cash Growth
17.98%-61.85%-44.54%-62.83%-69.34%-23.24%-36.89%-22.73%10.52%15.85%28.96%17.77%1.81%8.57%6.18%-24.45%-6.55%25.20%-4.27%247.12%
Net Cash Per Share
18.3418.3920.4016.0614.9246.2735.5841.9147.7159.4155.3453.0042.2050.0841.9344.1440.7245.4138.8557.52
Book Value
43,88243,95343,72242,50341,31543,77542,19140,60839,30638,42338,20537,35636,24335,99135,81235,97536,06035,73734,96833,853
Book Value Per Share
197.84196.48193.63187.07178.78187.79180.77173.39166.69162.47160.66155.84150.26148.60147.13147.20146.88145.27141.34136.39
Tangible Book Value
4,3384,1753,8642,1439447,4835,7823,9513,7162,6412,2281,1681,5451,0746831,1361,217804292,793
Tangible Book Value Per Share
19.5618.6617.119.434.0832.1024.7716.8715.7611.179.374.876.414.432.814.654.963.270.1211.25
Updated Jan 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q